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development
Abstract
During vertebrate development, neural crest cells are exposed to multiple extracellular cues that drive
their differentiation into neural and non-neural cell lineages. Insights into the signals potentially
involved in neural crest cell fate decisions in vivo have been gained by cell culture experiments that
have allowed the identification of instructive growth factors promoting either proliferation of
multipotent neural crest cells or acquisition of specific fates. For instance, members of the TGFbeta
factor family induce neurogenesis and smooth muscle cell formation at the expense of other fates in
culture. In vivo, conditional ablation of various TGFbeta signaling components resulted in
malformations of non-neural derivatives of the neural crest, but it is unclear whether these phenotypes
involved aberrant fate decisions. Moreover, it remains to be shown whether neuronal determination
indeed requires TGFbeta factor activity in vivo. To address these issues, we conditionally deleted
Smad4 in the neural crest, thus inactivating all canonical TGFbeta factor signaling. Surprisingly, neural
crest cell fates were not affected in these mutants, with the exception of sensory neurogenesis in
trigeminal ganglia. Rather, Smad4 regulates survival of smooth muscle and proliferation of autonomic
and ENS neuronal progenitor cells. Thus, Smad signaling plays multiple, lineage-specific roles in vivo,
many of which are elicited only after neural crest cell fate decision.
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Abstract
During vertebrate development, neural crest cells are exposed to multiple extracellular 
cues that drive their differentiation into neural and non-neural cell lineages. Insights into 
the signals potentially involved in neural crest cell fate decisions in vivo have been gained 
by cell culture experiments that have allowed the identification of instructive growth 
factors promoting either proliferation of multipotent neural crest cells or acquisition of 
specific fates. For instance, members of the TGF factor family induce neurogenesis and 
smooth muscle cell formation at the expense of other fates in culture. In vivo, conditional 
ablation of various TGF signaling components resulted in malformations of non-neural 
derivatives of the neural crest, but it is unclear whether these phenotypes involved 
aberrant fate decisions. Moreover, it remains to be shown whether neuronal 
determination indeed requires TGF factor activity in vivo. To address these issues, we 
conditionally deleted Smad4 in the neural crest, thus inactivating all canonical TGF
factor signaling. Surprisingly, neural crest cell fates were not affected in these mutants, 
with the exception of sensory neurogenesis in trigeminal ganglia. Rather, Smad4 
regulates survival of smooth muscle and proliferation of autonomic and ENS neuronal 
progenitor cells. Thus, Smad signaling plays multiple, lineage-specific roles in vivo, 
many of which are elicited only after neural crest cell fate decision.
Keywords : Neural crest; smooth muscle formation; autonomic neurogenesis; sensory 
neurogenesis; Smad4; TGF; BMP; cell survival; proliferation; fate decision
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Introduction
During development, multipotent cells have to proliferate and to adopt particular fates at 
the correct time and location to give rise to an appropriate number of differentiated cell 
types. A good example for this are neural crest cells that generate a variety of specialized 
cell types in vertebrates, including peripheral glia, sensory and autonomic neurons of the 
peripheral nervous system (PNS), the enteric nervous system (ENS), as well as pigment 
cells, smooth muscle in the cardiovascular system, and craniofacial chondrocytes and 
osteoblasts (reviewed in Le Douarin and Dupin, 2003). Studies performed with cultures 
of migratory and postmigratory neural crest cells have shed light on some of the growth 
factors, signaling pathways, and transcriptional programs that control neural crest cell 
fate decisions (reviewed in Delfino-Machin et al., 2007; Fuchs and Sommer, 2007). In 
particular, clonal cell culture assays revealed that certain growth factors have the capacity 
to instruct neural crest-derived stem cells (NCSCs) to adopt specific fates at the expense 
of other fates. However, to date only few of these signals have been demonstrated to 
indeed influence neural crest cell fate decisions in vivo. One exception to this is 
represented by Wnt/-catenin signaling that instructs migratory NCSCs to adopt a 
sensory fate in culture and that is both required for sensory neurogenesis and sufficient 
upon constitutive activation to promote this fate in vivo at the expense of other neural as 
well as non-neural fates (Hari et al., 2002; Lee et al., 2004). In contrast, neuregulin and 
Notch induce glial fates in cultured NCSCs, but inactivation of these signals still allows 
the formation of at least some peripheral glial lineages in vivo (reviewed in Woodhoo and 
Sommer, 2008). 
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Incubation of NCSCs in cultures with members of the TGF factor family, such as 
TGF1, 2 and 3 as well as BMP2 and 4, fosters either generation of sensory neurons, 
autonomic neurons or smooth muscle, or induces apoptosis, depending on the cellular 
context and the concentration of the factors (Shah et al., 1996; Hagedorn et al., 1999; 
Hagedorn et al., 2000; Lo et al., 2002; Ota and Ito, 2006). Ligands of the TGFβ factor 
family signal by bringing together two pairs of type I and type II receptors, respectively 
(Massague, 2008). There are different type I and II receptors that can interact with a set 
of distinct co-receptors, adding to the signaling complexity. Activation of these 
serine/threonine kinase receptors leads to signal propagation by phosphorylation of
Receptor-Smads (R-Smad) transcription factors, with Smads 2 and 3 mediating the 
activities of TGFβ isoforms, activins, and other ligands, and Smads 1, 5, and 8 the 
activities of BMPs and others. Once activated, R-Smads translocate to the nucleus to 
interact with Smad4, which is common to both TGF and BMP signaling pathways. This 
binding is required to elicit all transcriptional responses to so-called canonical TGF
factor signaling. Non-canonical signaling can also occur, however, and involves Smad4-
independent R-Smad signaling as well as Smad-independent receptor type I or II 
signaling.
Several of the above mentioned signaling components have been manipulated in vivo in 
the developing neural crest (Wurdak et al., 2006). With respect to TGF family ligands, 
inactivation of genes encoding TGF2 and TGF3 in mice resulted in severe craniofacial 
malformations, while BMP overexpression or blocking BMP by its inhibitor Noggin in 
developing chicken affected sympathetic ganglia formation (Reissmann et al., 1996; 
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Schneider et al., 1999; Dunker and Krieglstein, 2002; Wurdak et al., 2006). With respect
to receptors for TGF family factors, TGF type II receptor (Tgbfr2) and TGF type I 
receptor (Alk5) inactivation in the neural crest caused extensive craniofacial defects, such 
as cleft palate, and cardiovascular malformations including aortic arch patterning 
deficiencies, persistent truncus arteriosus, and septal defects (Ito et al., 2003; Ittner et al., 
2005; Wurdak et al., 2005; Choudhary et al., 2006; Dudas et al., 2006; Wang et al., 
2006). Similar defects, although not as severe, resulted from deletion of receptors 
mediating BMP responses (Dudas et al., 2004; Kaartinen et al., 2004; Stottmann et al., 
2004) Finally, ablation of the downstream mediator of canonical TGF signaling, Smad4, 
led to massive cell death and thus malformations in both craniofacial and cardiovascular 
neural crest derivatives (Jia et al., 2007; Ko et al., 2007) and to reduced size and altered 
patterning of trigeminal ganglia (Hodge et al., 2007; Ko et al., 2007). 
In view of the role of TGF factors in NCSC cultures, the question arises of whether the 
abovementioned phenotypes are possibly associated with failures in neural crest cell fate 
decisions in vivo. Given the partially overlapping and therefore potentially compensatory 
effects of TGF and BMP in neural crest cell cultures, we sought to address this question 
by inactivation of Smad4 in neural crest cells, hence preventing both canonical TGF and 
BMP signaling. Unexpectedly, canonical TGF factor signaling controls cell survival and 
proliferation in a cell lineage-specific manner, and generation of a trigeminal sensory 
sublineage, but appears not to be required for smooth muscle and autonomic neuronal 
fate acquisition. 
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Materials and methods
Generation of mutant animals
The Cre/loxP system was used to conditionally delete the C-terminal domain of the 
Smad4 protein (Yang et al., 2002) and to inactivate the TGF- type II receptor (Tgfbr2)
(Leveen et al., 2002; Wurdak et al., 2005). For a selective ablation in NCSCs the Wnt1-
Cre transgenic mouse line was used (Danielian et al., 1998). To obtain Wnt1-
Cre/Smad4lox/lox conditional knock out (mutant) embryos Smad4lox/lox mice were mated 
with Wnt1-Cre/Smad4lox/wt mice. Similar breedings were done to generate Wnt1-
Cre/Tgfbr2 lox/lox conditional knock out (mutant) embryos. In vivo fate mapping of neural 
crest cells was done by mating Wnt1-Cre/Smad4lox/wt mice with Smad4lox/lox carrying the 
ROSA26 Cre reporter (R26R) allele (Soriano, 1999).  Genotyping was done on genomic 
DNA by PCR using the primers pair 5’-GGC ACA TTA CAT TTG CAG TCA G-3’ and 
5’-AGG AAA AAC AGG GCT ATG TAG AA-3’ which gives a 282 bp band for the 
Smad4 wildtype allele and a 330 bp band for the floxed Smad4 allele. Genotyping for the 
Tgfbr2 floxed allele and Wnt1-Cre was done as described in (Hari et al., 2002; Wurdak et 
al., 2005).
Staining procedures
E9.5-E11.5 embryos were fixed in 4% PFA for 45 min to 2 hrs at room temperature (RT) 
according to their developmental stage. In situ hybridization on cryosections with 
digoxigenin-labelled probes and X-Gal detection of LacZ gene expression were 
performed as described in (Hari et al., 2002). Programmed cell death detection was done 
by TUNEL labeling (Roche) according to the manufacturer’s manual. 
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Immunohistochemistry was performed on cryo or paraffin sections. Antigen retrieval on 
paraffin sections was done in citrate buffer pH 6 in a steam cooker device (HistosPro, 
Milestone) at 110OC. Cryosections were fixed for 10 min in 4% PFA before staining. 
Cells were fixed in 4% formaldehyde for 10 min at RT. The following primary antibodies 
were used: Rabbit anti-Smad4 (1:100, Abcam), mouse anti-SMA (1:400, Sigma), mouse 
anti--Gal (1:100, Abcam), mouse anti-III-tubulin (1:300, Sigma), mouse anti-TH 
(1:300, Boehringer Mannheim), mouse anti-NF160 (1:500, Sigma), rat anti-Ki67 (1:50, 
DAKO), mouse anti-Mash1 (1:100, BD Biosciences), mouse anti-Sox10 (1:100, R&D), 
rabbit anti-p75 (1:300, Sigma), rabbit anti-Peripherin (Abcam), rabbit anti-pH3 (1:250, 
Upstate). All primary antibodies were detected by immunofluorescence with secondary 
antibodies from Jackson Immunoresearch or Molecular Probes except for anti-Smad4 and 
anti-Mash1 staining, which were visualized by Tyramide Signal Amplification using the 
TSA Plus Fluorescence System from Perkin Elmer (according to the manufacturers 
manual) and by the Vectastain method using NovaRed as a substrate (Vector 
Laboratories), respectively.
Cell Culture
Cultures of neural crest explants were done as previously described in (Kleber et al., 
2005). Defined medium (SN) was prepared as described in (Greenwood et al., 1999) and 
supplemented with 50 ng/ml BMP for induction of Mash1. For differentiation of NCSCs 
to smooth muscle cells, a defined medium supplemented with chicken embryonic extract 
(CEE) (referred to as standard medium (SM); Stemple and Anderson, 1992) and 1 ng/ml 
TGF-1 (PeproTech) was used. In some experiments, differentiation to smooth muscle 
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cells and the autonomic lineage was achieved by culturing NCSCs in an undefined 
medium composed of standard medium with 10% FBS (Invitrogen) and 5 M Forskolin 
(Sigma) for 5-12 days.
ENS sphere cultures were obtained by dissociating gut from E11.5 mouse embryos with 1 
mg/ml Collagenase I (Worthington) dissolved in HBSS- (Gibco). The neural crest-
specific neurosphere medium contained DMEM-F12 glutamax (Gibco), 20 ng/ml bFGF 
(PeproTech), 1% N2 supplement (Invitrogen), 2% B27 supplement (Invitrogen), 50 M 
-mercaptoethanol, 1% Penicillin/Streptomycin (Invitrogen), 15% CEE, 35 ng/ml 
retinoic acid (Sigma), 20 ng/ml IGF1 (PeproTech). The culture plates were coated with 
Poly (2-hydroxyethyl methacrylate) (Sigma) to prevent cells from adhering to the plastic 
surface. Neurospheres were passaged every 6 days. Differentiation of the neurospheres to 
the sympathetic lineage was done in undefined medium as described above. BMP 
(PeproTech) was used at a concentration of 25 ng/ml and Noggin (PeproTech) at 100 
ng/ml.
Smad4 in neural crest development – Büchmann-Møller et al 9
Results
Smad4 is required for survival but apparently not for fate acquisition of neural crest-
derived smooth muscle cells
To inactivate Smad4 in the neural crest, the Smad4 MH2 domain required for binding of 
phosphorylated R-Smads and other transcription factors was conditionally deleted by 
Wnt1-Cre (Fig. 1A) (Yang et al., 2002; Jia et al., 2007; Ko et al., 2007). Recombination 
of this conditional allele is reported to result in a Smad4 null allele (Yang et al., 2002). 
Cre activity was monitored by recombination-dependent -Galactosidase (-Gal) 
expression in the ROSA 26 reporter (R26R) strain (Soriano, 1999). Wnt1-Cre-mediated 
recombination efficiently deletes genes of interest in virtually all neural crest cells (Lee et 
al., 2004; Wurdak et al., 2005). Accordingly, Smad4 protein expression was abolished in 
mutant neural crest derivatives, such as in the pharyngeal arches (Fig. 1B,C). 
Premigratory and emigrating Smad4-deficient neural crest cells showed a normal 
expression of the NCSC markers Sox10 and p75 (Fig. 1 D,E) (Paratore et al., 2001) as 
well as of Neurogenin 2 (Ngn2), which is expressed in the early wave of the sensory 
lineage in the trunk (Fig. 1 F,G) (Sommer et al., 1996). At E10.5, in vivo fate mapping of 
-Gal-expressing cells revealed normal migration of Smad4-deficient neural crest cells to 
various locations, including the pharyngeal arches, dorsal root ganglia (DRG), and the 
gut (Fig. 1H,I). However, in accordance with earlier reports, conditional inactivation of 
Smad4 resulted in severe craniofacial defects (data not shown; Ko et al., 2007) and a 
shortened cardiac outflow tract (Fig. 2A,B) (Jia et al., 2007). This phenotype was 
accompanied by massive apoptosis in craniofacial structures and the pharyngeal 
apparatus (Ko et al., 2007), as illustrated by extensive TUNEL labeling in the area of the 
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fourth pharyngeal arch artery in mutant embryos at E11 (Fig. 2K,L). Mutant embryos 
were obtained at expected Mendelian ratios until E12. After E12.5, however, we were 
unable to collect any mutants, revealing a highly penetrant phenotype.
BMP2 and TGF are able to instructively promote a smooth muscle fate in cultured 
NCSCs (Shah et al., 1996). To address whether these factors might also regulate smooth 
muscle fate decision from neural crest cells in vivo, we performed immunostaining for 
smooth muscle actin (SMA) on sections of conditional knock out embryos, in which 
neural crest derivatives were marked by -Gal expression. Intriguingly, early formation 
of smooth muscle was found in mutant neural crest-derived tissue to a similar extent as in 
the control, such as the aortic sac and the 3. PAA at E10.5, when apoptosis was still 
scarcely detectable in these particular areas (Fig. 2C-H, and data not shown). In 
agreement with Jia et al. (2007) we found in the same embryos strongly increased 
apoptosis in the branchial arches. Although clearly reduced and accompanied by massive 
cell death, SMA was still detectable in mutant neural crest-derived pharyngeal arch 
arteries from E11 onwards (Fig. 2I-L; data not shown). 
Although smooth muscle formation was detectable in conditional knock out embryos, it 
is difficult to address in vivo whether loss of Smad4 interferes with smooth muscle fate 
acquisition, thereby leading to increased cell death, or whether Smad4-deficient neural 
crest cells are able to choose a smooth muscle fate, but then require Smad4 for survival. 
Therefore, to address this question on the cellular level, we used NCSC cultures, in which 
TGF family factors have been shown to promote smooth muscle fate decision (Shah et 
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al., 1996). Neural crest explant cultures were generated from neural tubes of control and 
conditional Smad4-knock out embryos at E9.5 (Hari et al., 2002). Sox10/p75-positive 
NCSCs emigrated from both control and mutant neural tubes (Fig. 3A,B). Virtually all of 
the control cells were positive for Smad4, while Smad4 protein expression was 
completely lost in mutant cultures (Fig. 3C-F). To promote differentiation, explants were 
cultured in standard medium containing chicken embryonic extract (CEE) in the presence 
or absence of TGF-1, as described in (Shah et al., 1996). While in control cultures, 
smooth muscle formation was strongly increased by the addition of TGF, Smad4-
deficient cultures were unable to respond to this growth factor and displayed only limited 
SMA immunostaining (Fig. 3G-J). Thus, TGF acts via canonical Smad signaling to 
instruct NCSCs to adopt a smooth muscle fate.
Given the presence of SMA-positive neural crest-derived cells in Smad4-conditional 
mutants (Fig. 2E-L), we next asked whether signals other than TGF/Smad4 might be 
able to induce smooth muscle formation in neural crest cells. To this end, explants were 
incubated in conditions permissive for smooth muscle generation (Stemple and 
Anderson, 1992) by culture in standard medium containing fetal bovine serum (FBS) and 
forskolin, which leads to enhanced cAMP production. Intriguingly, under these 
conditions, smooth muscle cells readily formed in both control and Smad4-deficient 
explants, and at 5 days of incubation there was no obvious difference in the extent of 
SMA expression (Fig. 3K,L). Thereafter, however, mutant smooth muscle cells began to 
die, and at 9 days of culture only few smooth muscle cells remained, even though many 
other, SMA-negative cells were still present in Smad4-deficient explants (Fig. 3M,N). In 
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contrast, control explants at 9 days contained large numbers of smooth muscle cells. 
These data indicate that Smad4 activity is not an absolute prerequisite for smooth muscle 
fate acquisition and differentiation per se, but controls survival and maintenance of these 
cells once formed from neural crest cells.
Smad4 controls sensory neuronal fate decision in trigeminal but not dorsal root ganglia
Apart from non-neural lineage regulation, TGF family factors have also been implicated 
in neuronal lineage generation from the neural crest. At stages of ongoing neurogenesis 
(E10.5), Smad1/5/8 (mediating BMP signaling) and Smad2/3 (mediating TGF
signaling) appear to be activated by phosphorylation in sensory ganglia (data not shown; 
Chuva de Sousa Lopes et al., 2004). Moreover, BMP signaling has been shown to control 
trigeminal ganglia size and patterning (Hodge et al., 2007; Ko et al., 2007). To address 
whether these findings reflect a role of Smad signaling in controlling sensory cell 
survival, we first assessed apoptosis in trigeminal ganglia and DRG of control and 
Smad4-conditional knock out embryos at E10.5 and E11.5. Unlike in mesenchymal 
neural crest derivatives including smooth muscle, loss of Smad4 did not affect cell 
survival in the sensory lineage (Fig. 4A,B,K,L and data not shown). Likewise, 
proliferation was unchanged in the mutant. 
Sensory neuronal fate decision involves the proneural transcription factors Neurogenin 
(Ngn) 1 and 2, with Ngn1 regulating the generation of  the TrkA-positive subpopulation 
of sensory neurons and Ngn2 the generation of TrkB/C-expressing sensory neurons (Ma 
et al., 1999). Intriguingly, we found that in the trigeminal ganglia at E10.5 Ngn1 
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expression requires Smad4, while it is independent of Smad4 in DRG and the vestibulo-
cochlear ganglia (Fig. 4C,D,M,N and data not shown). Impaired Ngn1 expression in 
mutant trigeminal ganglia was not simply due to delayed development, as it was also 
strongly reduced at E11.5 (data not shown). Accordingly, TrkA but not TrkB/C was 
virtually absent in Smad4-deficient trigeminal ganglia, indicating lack of this particular 
sensory lineage upon Smad signal inactivation (Fig. 4E-J). In contrast, TrkA, B, and C 
were normally expressed in mutant DRG (Fig. 4O-T).  
To address whether it is canonical TGF or BMP signaling that is involved in fate 
acquisition of the TrkA sensory lineage in trigeminal ganglia, the expression of Ngn1 and 
TrkA were analyzed in conditional knock out embryos, in which Tgfbr2 –encoding an 
essential receptor for TGF but not BMP signaling– had been ablated in the neural crest 
(Leveen et al., 2002; Wurdak et al., 2005). Unlike in conditional Smad4 knock out 
embryos, Ngn1 and TrkA expression were not affected in the trigeminal ganglia of 
Tgfbr2 mutants (Fig. 4, U-Y). Given that cell survival and proliferation were not altered 
in conditional knock out sensory ganglia, our data indicate that BMP/Smad signaling is 
involved in sensory neuronal fate decision specifically in trigeminal ganglia.
BMP/Smad4-independent autonomic neurogenesis
In neural crest cell cultures, TGF as well as BMP can promote autonomic neurogenesis 
in an instructive and context-dependent manner (Shah et al., 1996; Hagedorn et al., 1999; 
Hagedorn et al., 2000). Moreover, BMP signaling in chicken regulates autonomic ganglia 
formation, along with expression of the transcription factors Mash1 and Hand2 that 
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control autonomic neurogenesis (Guillemot et al., 1993; Sommer et al., 1995; Reissmann 
et al., 1996; Schneider et al., 1999; Howard et al., 2000). Thus, should Smad signaling be 
involved in promoting autonomic fate decision in vivo, one would expect reduced Mash1 
expression in Smad4-deficient autonomic ganglia. In contrast, however, loss of Smad4 in 
sympathetic ganglia at E10.5 (Fig. 5A,B) was not associated with altered Mash1 
expression, although the mutant ganglia were somewhat smaller than in the control (Fig. 
5E,F). Similarly, Mash1 was not affected in the mutant enteric nervous system (ENS) 
(data not shown). Likewise, expression of Hand2 was present in Smad4-deficient 
sympathetic ganglia at E10.5 (Fig. 5G,H). Moreover, neuronal differentiation occurred 
normally, as pan-neuronal markers such III-Tubulin as well as the autonomic 
differentiation marker tyrosine hydroxylase (TH) were readily detectable in ganglia 
lacking Smad4 (Fig. 5C,D and K,L). Of note, however, the size of sympathetic ganglia 
was clearly reduced in the mutant as compared to the control at E11 (Fig. 5I-L).
At first sight, our in vivo data seem to contradict previous findings obtained in vitro
pointing to instructive roles of TGF family factors in autonomic fate acquisition. One 
possibility explaining this discrepancy might be that TGF/BMP promote autonomic 
neurogenesis independently of Smad4 by a non-canonical pathway. In BMP2-treated 
NCSC explant cultures incubated in defined medium, Mash1 expression was completely 
abolished in the absence of Smad4, while it was strongly induced in control cultures (Fig. 
6A,B). Thus, persistence of Mash1 expression in ganglia lacking Smad signaling might 
indicate the existence of other signaling cues with the potential to induce autonomic 
neurogenesis. In vitro, elevated levels of cAMP (induced by forskolin) has been 
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described to support autonomic neurogenesis (Sarkar and Howard, 2006). Therefore, we 
incubated NCSCs in standard medium supplemented with FBS and forskolin, which is 
permissive (but not instructive) for an autonomic fate (Sommer et al., 1995). Strikingly, 
both Smad4-deficient NCSCs that have emigrated from the neural tube as well as mutant 
NCSCs derived from the ENS were able to give rise to Mash1-positive cells under these 
conditions (Fig. 6C,D and G,H). Moreover, fully differentiated neurofilament (NF)160-
positive autonomic neurons were generated in control and mutant NCSC explant cultures 
upon prolonged incubation for 12 days (Fig. 6E,F). Likewise, both control and mutant 
ENS NCSCs readily gave rise to neurons double-positive for Peripherin and TH (Fig. 6I,J 
and data not shown). To assess whether neurogenesis could occur because of incomplete 
Cre-mediated recombination, we performed fate mapping of ENS NCSCs carrying a 
recombined R26R allele. These cells can be tracked by a typically dotted staining for -
Gal (Lutolf et al., 2002). Both in control and mutant cultures, virtually all TH-positive 
neurons expressed -Gal (green labeling in Fig. 6I,J), demonstrating that appearance of 
TH-expressing neurons in the absence of Smad4 was not simply due to inefficient gene 
deletion. Similarly to the in vivo situation, however, ganglia-like structures obtained in 
cell cultures were smaller in the mutant than in the control. 
In defined medium, addition of Noggin, an efficient inhibitor of BMP signaling 
(Zimmerman et al., 1996), reversed the neurogenic effect of BMP, abolishing Mash1 
expression in NCSCs from the ENS (Fig. 6K-M). To confirm that neurogenesis can be 
promoted from NCSCs in a BMP/Smad-independent manner, we exposed control and 
Smad4-mutant NCSCs from the ENS in FBS/forskolin-containing medium to Noggin. 
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When incubated in this complex medium, Smad4-deficient NCSCs were able to generate 
Mash1-positive progenitors and Peripherin/TH-double-positive neurons, even in the 
presence of Noggin (Fig. 6N-Q). Thus, factors other than BMP/Smad can promote 
generation of Mash1-dependent TH-positive neurons. Again, however, mutant cultures 
gave rise to fewer TH-positive neurons as compared to control cultures, suggesting that in 
the chosen context Smad signaling might control numbers of neurons rather than 
acquisition of their fate.
Smad4 controls proliferation of autonomic and ENS neuronal progenitor cells
The size reduction of Smad4-deficient autonomic ganglia in vivo and of ganglia-like 
structures in mutant cell cultures might reflect a role of Smad signaling in the control of 
cell survival, as in neural crest-derived smooth muscle, or in proliferation. To address this 
point we first performed TUNEL labeling for programmed cell death in control and 
conditional knock out embryos at E10.5 and quantified the number of apoptotic cells in 
sympathetic ganglia. Apoptosis was low at this stage, and there was no change in the 
number of apoptotic cells upon loss of Smad4 (Fig. 7A). In contrast, staining for the 
mitotic marker Ki67 revealed a highly significant decrease in the number of proliferative 
NF160-positive cells in Smad4-deficient as opposed to control sympathetic ganglia at 
E11.5 (Fig. 7B-D). Thus, Smad signaling regulates proliferation of autonomic neuronal 
progenitors in vivo.
The above experiments reveal a mitogenic role of Smad4 in neuronal progenitors, but 
they did not directly address whether Smad signaling might also control stem cell self-
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renewal. To address this issue, and to confirm the in vivo data by an independent 
approach, we generated non-adhesive ENS sphere cultures from control and conditional 
knock out gut at E11.5 (Kruger et al., 2002; Fuchs et al., 2009). In this system, stem cell 
self-renewal can be monitored by serial sphere passaging, while the sphere size is 
indicative of progenitor cell proliferation. Self-renewal as assessed by determining the 
ratios between secondary per primary and tertiary per secondary sphere numbers was not 
affected upon Smad4 inactivation (Fig. 7E). Accordingly, both control and mutant 
spheres could be serially propagated over several passages (Fig. 7H). However, in all 
passages, the average sphere size was significantly reduced in the Smad4-deficient 
cultures. In particular, spheres with a diameter larger than 100μm were reduced by more 
than 70% in quartenary mutant spheres, whereas in the same passage the number of 
spheres with a diameter smaller than 50m was strongly increased by 260% (Fig. 7I). In 
sum, proliferation of autonomic and ENS progenitor cells, but not of postmigratory 
NCSCs, is controlled by Smad signaling.
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Discussion
Experimental culture systems of neural crest cells have successfully been used not only to 
determine the self-renewal capacity of NCSCs, but also to identify growth factors
instructively promoting stem cell maintenance and lineage decisions (Le Douarin and 
Dupin, 2003; Fuchs and Sommer, 2007). Based on cell culture experiments, TGF family 
factors have been implicated in both non-neural and neuronal fate decisions by NCSCs 
(Shah et al., 1996; Hagedorn et al., 1999; Lo et al., 2002; Ota and Ito, 2006). Several 
studies demonstrated an in vivo role of TGF factor signaling in the generation of non-
neural as well as neuronal derivatives from the neural crest (Schneider et al., 1999; Ito et 
al., 2003; Kaartinen et al., 2004; Stottmann et al., 2004; Ittner et al., 2005; Wurdak et al., 
2005; Choudhary et al., 2006; Dudas et al., 2006; Wang et al., 2006; Hodge et al., 2007; 
Jia et al., 2007; Ko et al., 2007; Mancini et al., 2007). However, the implication of TGF
factors in actual fate choice by neural crest cells in vivo has remained unclear. Here we 
found that inactivation of canonical TGF factor signaling in neural crest cells by 
conditional deletion of Smad4 has surprisingly little effects on neural crest cell fate 
decisions in vivo, with the notable exception of sensory neuronal fate acquisition in 
trigeminal ganglia. In contrast, sensory lineages in DRG were unaffected upon Smad4
deletion. Likewise, Smad4-deficient neural crest cells were able to adopt both an 
autonomic neuronal and a smooth muscle fate, although the mutation influenced 
proliferation and survival, respectively, in these lineages. A possibly involvement of 
Smad signaling in fate acquisition might not be apparent in the mutants in vivo, given that 
in culture compensatory mechanisms can promote autonomic and smooth muscle fates 
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independently of Smad4. Overall our data reveal multiple roles of Smad signaling during 
neural crest cell development that are specific for different neural crest-derived lineages.
Smad4-independent generation of neural crest-derived smooth muscle cells 
Smad4 inactivation in the cranial neural crest results in many severe cardiovascular and 
craniofacial defects, as has been described before in detail (Jia et al., 2007; Ko et al., 
2007). Similar anomalies were also observed after conditional ablation of other TGF
signaling components, including TGF family ligands and receptors (Wurdak et al., 
2006). For instance, ablation of Tgfbr2 in neural crest cells leads to various 
cardiovascular and craniofacial malformations reminiscent of DiGeorge syndrome 
(Wurdak et al., 2005). Moreover, the shortened outflow tract of Smad4 mutants resembles 
the phenotype found in embryos lacking the BMP receptors Alk2 and Alk3 in neural crest 
cells and their derivatives (Kaartinen et al., 2004; Stottmann et al., 2004). However, the 
phenotypes in these cases were less severe and not accompanied by massive cell death, as 
observed in conditional Smad4 knock out embryos. In contrast, ablation of the TGF type 
1 receptor Alk5 in neural crest cells resulted in craniofacial and cardiac outflow tract 
phenotypes very similar to the ones found upon neural crest-specific Smad4 inactivation 
(Dudas et al., 2006; Wang et al., 2006). In particular, Alk5 deficiency was also associated 
with extensive cell death in neural crest-derived tissue, suggesting that disturbed 
signaling by ligands that act via Alk5 (such as, for instance, GDF11) might mainly 
contribute to the phenotype observed in Smad4 mutants. This does not exclude further 
functions of Smad4 in craniofacial and cardiovascular development, including BMP-
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mediated neural crest cell migration to the outflow tract or proliferation promoted by 
TGF during palatogenesis (Ito et al., 2003; Kaartinen et al., 2004; Sasaki et al., 2005). 
Importantly, although smooth muscle differentiation appears to be locally disturbed in 
some mouse lines lacking TGF signaling components in neural crest cells (Kaartinen et 
al., 2004; Wurdak et al., 2005), absence of canonical TGF factor signaling is compatible 
with smooth muscle cell formation per se (Figs. 2 and 3). In particular, we show that 
TGF-induced smooth muscle formation from NCSCs in culture indeed requires Smad4, 
but that other pathways, as activated by serum factors, are able to promote smooth muscle 
formation even in the absence of Smad4. These factors could act via RhoA that in culture 
can mediate TGF-induced smooth muscle formation (Chen et al., 2006). However, 
conditional inactivation of RhoA in vivo does not produce any overt neural crest lineage 
deficiencies during development, inconsistent with a role of RhoA signaling in smooth 
muscle formation (Falk S., Brakebush C., and Sommer L., unpublished). This function 
might be fulfilled by signaling through the TGF co-receptor endoglin that is required for 
smooth myogenesis in culture and promotes increased smooth muscle formation upon 
overexpression, possibly in a Smad4-independent manner (Mancini et al., 2007). Cells 
having acquired a smooth muscle fate in culture, however, are dependent on Smad 
signaling for survival. These findings are compatible with our in vivo data, since smooth 
muscle cells are present around the aortic sac and arteries in Smad4-deficient embryos, 
becoming reduced only after initial formation. Thus, in vivo development of smooth 
muscle in neural crest derivatives appears to involve both canonical TGF factor 
signaling as well as alternative signaling pathways. 
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Signaling pathways promoting sensory fate acquisition in NCSCs
An established key player in sensory fate decision by early NCSCs is canonical Wnt/-
catenin signaling (Kleber and Sommer, 2004) NCSCs, in which -catenin has been 
conditionally ablated, fail to generate both a first wave of Ngn2-dependent TrkB/C-
positive sensory neurons and a second wave of Ngn1-dependent TrkA-positive sensory 
neurons (Hari et al., 2002). Moreover, constitutive activation of -catenin in the neural 
crest promotes a sensory fate in dorsal root and cranial ganglia at the expense of all other 
possible neural crest cell fates in vivo (Lee et al., 2004). Thereby, Wnt/-catenin provides 
an instructive signal for sensory fate specification, as shown in NCSC cultures. Further 
cell culture experiments suggested that low doses of BMP2/4 could also promote 
generation of Ngn2- and Ngn1-positive cells and sensory neuronal differentiation in 
neural crest cells from trunk neural tube (Lo et al., 2002; Ota and Ito, 2006). However, 
our study does not support an in vivo role of TGF factor signaling in sensory 
neurogenesis in the trunk, as neither the generation of TrkB/C- nor of TrkA-expressing 
DRG neurons was affected in conditional Smad4-knock out embryos. 
Intriguingly, Smad signaling does play a role in sensory fate decision in trigeminal 
ganglia. In these cranial ganglia, neural crest-derived cells adopting a sensory fate 
express Ngn1 but not Ngn2 (Sommer et al., 1996; Ma et al., 1999). Ngn1 expression as 
well as the generation of TrkA-positive sensory neurons depends on Smad4, while Smad 
signaling does not influence cell survival or proliferation (Fig. 4). Thus, unlike in DRG, 
sensory fate specification in trigeminal ganglia is controlled by Smad activity. The ligand 
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mediating this effect is a BMP factor rather than a TGF  isoform, because sensory 
neurogenesis was normal in trigeminal ganglia lacking Tgfbr2, which mediates TGF but 
not BMP signaling. An earlier study by Hodge et al. (2007) revealed a role of Smad4 and 
retrograde BMP signaling in trigeminal ganglia patterning and the establishment of 
appropriate central projections. We propose that these patterning and projections defects, 
apparent in Wnt1-Cre/Smad4 mutant embryos at E11.5 (Hodge et al., 2007), might 
involve impaired sensory fate decision and consequent loss of Ngn1-expressing neuronal 
progenitors, as revealed in the present work in mutant embryos at E10.5.
Smad signaling regulates proliferation but not fate acquisition of autonomic neuronal 
progenitor cells
Based on multiple evidence obtained in vitro and in vivo, a strong point was made that 
TGF factor signaling regulates autonomic fate specification (reviewed in Huber, 2006). 
BMP2/4 and, depending on the cellular context, TGF were shown to promote autonomic 
neurogenesis in NCSC cultures (Shah et al., 1996; Hagedorn et al., 1999; Hagedorn et al., 
2000). In addition, BMPs are expressed in the dorsal aorta close to the site of sympathetic 
ganglia formation (Reissmann et al., 1996), and expression of Mash1 as well as Hand2, 
both key players in autonomic neurogenesis, can be regulated by BMPs (Shah et al., 
1996; Howard et al., 2000). Functionally, local overexpression of BMP in chicken 
embryos increased the size of adjacent sympathetic ganglia and even led to the 
appearance of ectopic cells with a sympathetic phenotype (Reissmann et al., 1996). In 
contrast, inhibition of BMP signaling by Noggin reduced sympathetic ganglion size, 
although initial ganglia formation was not affected (Schneider et al., 1999). Our data now 
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provide a novel, alternative explanation for these results: Rather than influencing an 
autonomic fate choice, canonical TGF factor signaling controls sympathetic ganglion 
size by regulating proliferation of autonomic neuronal progenitors. Indeed, Mash1, 
Hand2 as well as TH were expressed in sympathetic ganglia formed by Smad4-deficient 
neural crest derived cells (Fig. 5), although the mutant ganglia were considerably smaller 
than their wild type counterparts. Culture experiments in defined medium conditions 
revealed that, similar to the action of TGF in smooth muscle formation, BMP2 can 
promote Mash1 expression and autonomic neurogenesis in a Smad-dependent manner 
(Fig. 6). However, at least in culture, other factors can compensate for BMP signaling 
and induce the generation of autonomic neurons even in neural crest cells lacking Smad4
(Nakajima et al., 2008 and this study). Thereby, compensatory cues do not rely on non-
canonical BMP signaling, since Mash1-dependent neurogenesis can also occur in the 
presence of Noggin that inhibits BMP signaling by sequestering the ligand. Such 
compensatory mechanisms might also explain why production and maintenance of early 
migratory NCSCs is apparently not affected in vivo in conditional Smad4 knock out 
embryos, despite the reported role of BMP in NCSC delamination and expansion in 
culture (Sela-Donenfeld and Kalcheim, 1999; Kleber et al., 2005). cAMP and protein 
kinase A (PKA) activation have been implicated before in BMP/Smad-independent 
differentiation of sympathetic neurons in vitro (Liu et al., 2005), although cAMP is 
believed to represent a permissive rather than an instructive cue (Sarkar and Howard, 
2006). According to these studies, however, PKA modulates Hand2 on the 
posttranslational level and would therefore not compensate for BMP signaling to regulate 
Hand2 mRNA expression in Smad4-conditional knock out embryos (in which we see 
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normal expression of Hand2 mRNA by in situ hybridization; Fig. 5). Furthermore, 
deletion of the gene encoding CREB (cAMP response element-binding protein), which 
mediates cAMP signaling, does not affect autonomic neuronal fate specification, but 
rather neuronal cell survival (Lonze et al., 2002). We conclude that canonical BMP 
signaling is either not at all involved in autonomic fate decision in vivo or is compensated 
for this function in Smad4 mutants by factors that remain to be identified.
The size of sympathetic ganglia is determined first by progenitor cell maintenance and 
proliferation, followed by proliferation of cells that have already acquired sympathetic 
neuronal traits (Tsarovina et al., 2008). Thus, unlike for instance in sensory ganglia 
where differentiation is coupled to cell cycle exit, proliferative neuronal cells contribute 
to a large extent to sympathetic ganglia development. While at early developmental 
stages Notch signaling controls maintenance of undifferentiated progenitor cells 
(Tsarovina et al., 2008), we identified in the present study Smad signaling as a crucial 
regulator of the sympathetic neuronal pool size. Indeed, the reduced size of sympathetic 
ganglia in Smad4-conditional mutants is brought about by significantly decreased 
proliferation of neuronal cells in the ganglia, while cell death was unaffected (Fig. 7). 
Likewise, progenitor proliferation but not NCSC self-renewal was affected in Smad4-
deficient neural crest-derived cells from the ENS. Smad-dependent proliferation of ENS 
cells might be linked to the migration defects and hypoganglionosis observed upon BMP 
signal inactivation, and giant ganglia formation found upon BMP overexpression in the 
gut (De Santa Barbara et al., 2005; Goldstein et al., 2005). 
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The role of Smad signaling in neuronal progenitors of the autonomic and ENS lineages, 
rather than in undifferentiated stem/progenitor cells, is different from the reported 
activities of TGF and Smad in controlling self-renewal by hematopoietic and midbrain 
neuroepithelial stem cells (Karlsson et al., 2007; Falk et al., 2008). This underlines the 
cell type- and context-specific functions elicited by canonical TGF factor signaling. 
During neural crest cell development, Smad signaling is associated with multiple cellular 
processes that include smooth muscle survival, sensory fate decision in trigeminal 
ganglia, and proliferation of autonomic neurons. How these Smad-dependent processes 
are further modulated in vivo by other signaling pathways, including non-canonical 
TGF/BMP signaling and TGF factor-independent pathways eliciting similar and 
partially overlapping effects, remains to be elucidated.
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Figure legends
Figure 1. Premigratory and emigrating neural crest cells are not affected by disrupted 
Smad signaling. (A) Exon 8 of Smad4 was conditionally deleted by activity of the Wnt1-
Cre transgene, yielding a truncated form of Smad4 protein lacking the MH2 domain and 
resulting in a null mutant. (B, C) Immunohistochemistry of Smad4 in pharyngeal arch 1. 
In control embryos Smad4 was abundantly expressed (B), while the protein was 
abolished in neural crest-derived tissue in Smad4 conditional knock out (cko) embryos 
(C). Arrow in C points to ectodermal tissue, arrowhead to endodermal tissue that were 
Smad4 positive, since these tissues are not neural crest derived and not recombined. 
(D,E) Immunohistochemistry for the neurotrophin receptor p75 (red) and Sox10 (green). 
DAPI (blue), (nt) neural tube. (F, G) Ngn2 in situ hybridization. Smad4-deficient NCSCs 
at E9.5 express the early neural crest markers p75, Sox10, and Ngn2 at normal levels. 
Arrows in (D,E) show p75 positive neural crest cells delaminating from the roof plate of 
the neural tube and arrow heads point to p75/Sox10-expressing migratory NCSCs. In 
(F,G), Ngn2–positive neural crest cells emigrate from the dorsal part of the neural tube in 
control and mutant. (H,I) In vivo fate mapping of neural crest cells using R26R on whole 
mount embryos at E10.5. Smad4-mutant neural crest cells reach their postmigratory 
targets, such as the pharyngeal arches (white arrowhead), DRGs (arrow), and the gut 
(black arrowhead). Scale bars: (C) 75 M, (G) 50 M, (I) 2 mm. 
Figure 2. Cell death in areas of smooth muscle development upon Smad4-deletion in 
neural crest cells. (A-F and I,J) In vivo fate mapping by R26R. (G,H,K and L) 
Immunostaining for SMA (green) along with TUNEL labelling for apoptosis (red). (A, B) 
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Whole heart at E10.5. The heart of the Smad4 mutant (B) shows a shortened outflow 
tract. (C-H) Formation of smooth muscle cells (arrows in G,H) is found in the -Gal 
positive (X-Gal) neural crest-derived tissue of the aortic sac (square in C,D enlarged in 
E,F), while apoptosis is barely detectable yet (arrow heads in H). (E,G) and (F,H), 
respectively, are adjacent sections. Note strong SMA staining in -Gal negative tissue not 
derived from the neural crest marked by dotted lines in (E-H). (K, L) SMA formation and 
TUNEL in the area of the neural crest-derived fourth pharyngeal arch artery (see fate 
mapping on adjacent sections in I, J). Note increased apoptosis in the mutant neural crest-
derived tissue (arrow heads) and decreased SMA expression, compared to control tissue 
(arrow). (BA1) branchial arch 1, (da) dorsal aorta, (la) left atrium, (lo) lining of the 
laryngeal orifice, (lv) left ventricle, (OFT) cardiac outflow tract, (PAA) pharyngeal arch 
artery, (ra) right atrium, (rv) right ventricle. Scale bars: (B) 0.5 mm, (D) 200 M , (H) 
and (L) 100 M.
Figure 3. Smad4 is required for survival but is not a prerequisite for fate acquisition of 
neural crest-derived smooth muscle cells. Immunocytochemistry of neural crest cells in 
neural tube explant cultures. (A, B) Smad4-deficient NCSCs express the neural crest 
markers Sox10 (green) and p75 (red), as do control cultures. (C-F) Absence of Smad4 
(red) expression in mutant neural crest explants. (E,F), same frame as in (C,D), but with 
DAPI (blue) staining revealing cell nuclei. (G-J) While control explants produce more 
smooth muscle cells (SMA (red)) in response to TGF, Smad4-deficient NCSCs do not 
respond to TGF when cultured in standard medium. (K-N) After 5 days (5 d) in standard 
medium containing FBS and forskolin, mutant NCSCs are able to acquire a smooth 
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muscle fate (K,L), but the smooth muscle cells were dependent on Smad4 for survival. 
After 9 days in culture there are hardly any smooth muscle cells left in mutant explant 
cultures (M, N). Scale bars: (J) 50 M, (N) 250 M.
Figure 4. Smad4 is required for sensory lineage decision in the trigeminal ganglia. (A, B, 
K, L) Immunohistochemistry and TUNEL of trigeminal ganglia and DRG at E10.5. 
There are no differences between mutant and control tissue with regard to proliferation 
(pH3, white), apoptosis (TUNEL, red), and Sox10 expression (green). (C-J, M-Y) In situ
hybridizations. (C,D) Ngn1 is almost absent in the Smad4-mutant trigeminal ganglia at 
E10.5, which results in deficient expression of TrkA at E11.5 (E, F). (G-J) TrkB and 
TrkC expression in the trigeminal ganglia are not affected by loss of Smad4. Similarly, 
Ngn1 and TrkA, B and C are normally expressed in mutant DRGs (M-T). (U-Y) Ngn1 
and TrkA are expressed in trigeminal ganglia of conditional Tgfbr2 knock out embryos at 
E11.5, which shows that the Ngn1-TrkA sensory lineage is dependent on Smad signaling 
via BMP ligands. Scale bars: (J) and (Y) 100 M, (T) 50 M.
Figure 5. Differentiation of NCSCs to autonomic neurons is independent of Smad4. (A-
D) Immunohistochemistry. The pan-neuronal marker III-tubulin (green) is expressed in 
the sympathetic ganglia at E10.5 in the absence of Smad4 protein (red), as shown on 
adjacent sections. The sympathetic ganglia are marked by dashed lines in (A and B). (E-
H) In situ hybridizations. In the mutant, the autonomic markers Mash1 and Hand2 are 
expressed at normal levels at E10.5. (I-L) Immunohistochemistry. At E11, mutant 
sympathetic ganglia are smaller than control ganglia, but neurons lacking Smad4 (red; 
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arrow in J) express the autonomic differentiation marker TH (green). (I,K) and (J,L) are 
adjacent sections. Scale bar: 50 M.
Figure 6. Compensatory factors inducing NCSCs to differentiate into autonomic neurons 
in the absence of BMP/Smad4 signaling. (A-F) Neural crest explant cultures, (G-Q) 
plated ENS spheres. (A, B) Mash1 induction is dependent on canonical BMP signaling 
when NCSCs are differentiated in defined medium (SN) with BMP. (C-F) In contrast, 
expression of Mash1 (dark grey) and NF160 (green) is independent of Smad4 signaling 
in medium (SM) containing FBS and forskolin. (G-J) Control as well as Smad4-deficient 
ENS cells express Mash1 (G-H) and differentiate into neurons positive for both TH (red) 
and Peripherin (white) (I, J) in medium with FBS and forskolin. -Gal (green) shows that 
Cre-mediated recombination has taken place. Inset, magnification of neuron (arrow) 
displayed in (J). Arrowheads, -Gal staining. (K-M) Noggin prevents BMP-induced 
Mash1 expression in ENS sphere cells. ENS spheres in defined medium display some 
Mash1-positive cells, revealing endogenous BMP activity (K). When exposed to BMP, 
Mash1 expression is strongly increased (L), but Noggin inhibits both the endogenous and 
the BMP-induced expression of Mash1 (M). (N-Q) Both control and Smad4-mutant ENS 
cells cultured in medium containing FBS, forskolin, and Noggin are able to give rise to 
neuronal cells, as shown by staining for Mash1 (N, O), and TH (red), Peripherin (white), 
and -Gal (green). Scale bar: 50 M.
Figure 7. Decreased proliferation in sympathetic ganglia and ENS progenitor cells in the 
absence of Smad4. (A) Equal extent of apoptosis in control and Smad4-mutant 
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sympathetic ganglia at E10.5. TUNEL-positive cells in ganglia were counted, and the 
ratio between apoptotic cells and all ganglionic cells was calculated. Control (dark grey 
bars), mutant (light grey bars). (B-D) There are significantly less neuronal progenitors in 
cell cycle in mutant than in control sympathetic ganglia. All NF (green) positive cells and 
all NF/Ki67 (red) double positive cells were counted (C,D). To get the percentage of 
proliferating neuronal progenitors, the ratio between double positive cells and all NF-
positive cells was determined. (E-I) ENS neurosphere assay. (E) Self-renewal is not 
affected in Smad4-mutant spheres. (F,G) Examples of average-sized control and mutant 
spheres. (H) The difference in size between control and mutant ENS spheres is 
statistically significant from the first to the fourth passage. (I) Distribution of sphere sizes 
in first and fourth passage. There is a significant increase in the number of small spheres 
(less than 50 M) and a decrease in spheres sized between 100-150 M in the mutant. 
(***, p < 0.05). Scale bars: (D) 30 M and (G) 50 M.
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